Please ensure Javascript is enabled for purposes of website accessibility

This Marijuana Stock Just Raised Guidance -- Time to Buy?

By Lee Samaha – Jun 19, 2020 at 8:07AM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Scotts Miracle-Gro sales have received a boost due to the COVID-19 pandemic, but is it sustainable?

Buy on the rumor and sell on the news. While long-term investors should, and do, usually ignore such maxims, it's worth noting that such short-term trading movements do influence the timing of an entry point into a stock. These matters should concern potential investors in Scotts Miracle-Gro (SMG -1.71%) because they go a long way toward explaining what's going on with the stock right now. Here's a look at what happened and an investment appraisal for the company.

The rumor

The company's second-quarter earnings release in May probably created a lot more than a rumor that its full-year guidance would have to be raised eventually. After all, overall sales were up 18% in the first half, with sales in the U.S. consumer segment (lawn and gardens) up 11% and Hawthorne (hydroponics for cannabis and indoor gardens) up a whopping 51%. However, at the time management merely maintained guidance for full-year U.S. consumer sales to be up 1% to 3%, while Hawthorne full-year sales guidance was only raised to 30% to 35% from 12% to 15% previously. Overall full-year sales were expected to grow just 6% to 8%.

A cannabis plant.

Image source: Getty Images.

The guidance looked excessively conservative, but management explained that its sales can be highly volatile and promised an update on full-year guidance in June.

Fast-forward to the update on June 8, and investors got the hike in guidance that the market had been merrily pricing in through May.

For reference, here are the key numbers from the update, and as you might expect from the opening line of this article, the market started selling off the stock in the days following the announcement.

Scotts Miracle-Gro Full-Year 2020 Guidance


At May 2020

At November 2019

U.S. Consumer revenue growth




Hawthorne revenue growth




Total revenue growth








Data source: Scotts Miracle-Gro presentations.

COVID-19 pandemic is a plus for Scotts Miracle-Gro

There aren't many companies that have prospered as a consequence of the pandemic, but Scotts is arguably one of them. When faced with extended lockdowns and social isolation measures, it's perfectly understandable if consumers turned attention to gardening and smoking pot. Indeed, management said as much on the second-quarter earnings call

It's all led to bumper sales growth at Scotts, with CEO Jim Hagedorn noting that sales were up 19% on a year-to-date basis in early June with "a nearly 40 percent increase in consumer purchases of Miracle-Gro branded soils and more than 30 percent increase in plant food." Meanwhile, the company remains on track to hit its operating margin guidance of 10% for 2020.

A temporary high?

Based on the midpoint of management's EPS guidance and the current stock price of around $131, Scotts trades on nearly 23 times 2020 earnings. Inevitably, investors' minds will turn to the question of whether that's a reasonable valuation for a company experiencing a sales boost that might not repeat in the coming years.

It's a difficult question to answer, because it's far from clear if the new interest in gardening and growing pot will be lasting, or whether sales will drop back next year.

A woman planting something in a garden

Image source: Getty Images.

Two reasons to get excited

That said, investors have cause for optimism for two reasons. First, during the sales update, Hagedorn referenced strong sales growth for Hawthorne in emerging markets like "Michigan, Oklahoma and Florida" in addition to "older markets like California and Colorado." In other words, Hawthorne is seeing growth by geography as well as organic growth due to the effects of COVID-19.

Second, going back to the first-quarter earnings -- which ended on Dec. 28 -- Scotts also saw strong growth with overall sales up 23%. U.S. consumer sales grew 8% and Hawthorne sales increased 41% in the first quarter. Given that the quarter came before the effects of COVID-19, it's fair to argue that Scotts had good underlying sales momentum in both its segments, even before the pandemic struck.

A stock to buy?

The two factors above give confidence that Scotts can continue to grow in 2021, and investors should be looking at the current dip in the share price as a possible buying opportunity. The stock is nowhere near as cheap as it was a few months ago, but then again that was before the big upgrade in 2020 expectations. It's definitely a stock to keep an eye on, with a view to buying if investors keep "selling on the news."

Lee Samaha has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Scotts Miracle-Gro. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

The Scotts Miracle-Gro Company Stock Quote
The Scotts Miracle-Gro Company
$49.95 (-1.71%) $0.87

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/25/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.